Advertisement
Singapore markets closed
  • Straits Times Index

    3,287.75
    -5.38 (-0.16%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • Dow

    38,460.92
    -42.77 (-0.11%)
     
  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     
  • Bitcoin USD

    62,877.92
    -3,205.84 (-4.85%)
     
  • CMC Crypto 200

    1,346.07
    -36.50 (-2.64%)
     
  • FTSE 100

    8,054.65
    +14.27 (+0.18%)
     
  • Gold

    2,333.20
    -5.20 (-0.22%)
     
  • Crude Oil

    82.37
    -0.44 (-0.53%)
     
  • 10-Yr Bond

    4.7230
    +0.0710 (+1.53%)
     
  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • FTSE Bursa Malaysia

    1,569.25
    -2.23 (-0.14%)
     
  • Jakarta Composite Index

    7,155.29
    -19.24 (-0.27%)
     
  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

Is This Dividend Growth Stock a Buy?

Is This Dividend Growth Stock a Buy?

The pharma stock Eli Lilly (NYSE: LLY) has surged 13% higher year to date. Let's dive into Eli Lilly's fundamentals and valuation to find out. Eli Lilly reported $7.8 billion in revenue for the first quarter ended March 31, up 14.8% from the year-ago period.